ESR1 and breast carcinoma: Thus, we carried out a longitudinal molecular imaging investigation using 18F-FES, 18F-FDG, and 18F-FMISO PET probes for early prediction and monitoring of the response to endocrine therapy in a mouse xenograft model of ER+ breast cancer s in this preclinical study.